These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 24854405)

  • 1. Using 'dead or dependent' as an outcome measure in clinical trials in Parkinson's disease.
    McGhee D; Parker A; Fielding S; Zajicek J; Counsell C
    J Neurol Neurosurg Psychiatry; 2015 Feb; 86(2):180-5. PubMed ID: 24854405
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Clinical effectiveness and cost-effectiveness of physiotherapy and occupational therapy versus no therapy in mild to moderate Parkinson's disease: a large pragmatic randomised controlled trial (PD REHAB).
    Clarke CE; Patel S; Ives N; Rick CE; Woolley R; Wheatley K; Walker MF; Zhu S; Kandiyali R; Yao G; Sackley CM
    Health Technol Assess; 2016 Aug; 20(63):1-96. PubMed ID: 27580669
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A responsive outcome for Parkinson's disease neuroprotection futility studies.
    Elm JJ; Goetz CG; Ravina B; Shannon K; Wooten GF; Tanner CM; Palesch YY; Huang P; Guimaraes P; Kamp C; Tilley BC; Kieburtz K;
    Ann Neurol; 2005 Feb; 57(2):197-203. PubMed ID: 15668964
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Coenzyme Q10 for Parkinson's disease.
    Liu J; Wang L; Zhan SY; Xia Y
    Cochrane Database Syst Rev; 2011 Dec; (12):CD008150. PubMed ID: 22161420
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A double-blind, placebo-controlled and longitudinal study of riluzole in early Parkinson's disease.
    Jankovic J; Hunter C
    Parkinsonism Relat Disord; 2002 Mar; 8(4):271-6. PubMed ID: 12039422
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Measuring disease progression in early Parkinson disease: the National Institutes of Health Exploratory Trials in Parkinson Disease (NET-PD) experience.
    Parashos SA; Luo S; Biglan KM; Bodis-Wollner I; He B; Liang GS; Ross GW; Tilley BC; Shulman LM;
    JAMA Neurol; 2014 Jun; 71(6):710-6. PubMed ID: 24711047
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Simvastatin as a neuroprotective treatment for Parkinson's disease (PD STAT): protocol for a double-blind, randomised, placebo-controlled futility study.
    Carroll CB; Webb D; Stevens KN; Vickery J; Eyre V; Ball S; Wyse R; Webber M; Foggo A; Zajicek J; Whone A; Creanor S
    BMJ Open; 2019 Oct; 9(10):e029740. PubMed ID: 31594876
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Validating the Berg Balance Scale for patients with Parkinson's disease: a key to rehabilitation evaluation.
    Qutubuddin AA; Pegg PO; Cifu DX; Brown R; McNamee S; Carne W
    Arch Phys Med Rehabil; 2005 Apr; 86(4):789-92. PubMed ID: 15827933
    [TBL] [Abstract][Full Text] [Related]  

  • 9. TCH346 as a neuroprotective drug in Parkinson's disease: a double-blind, randomised, controlled trial.
    Olanow CW; Schapira AH; LeWitt PA; Kieburtz K; Sauer D; Olivieri G; Pohlmann H; Hubble J
    Lancet Neurol; 2006 Dec; 5(12):1013-20. PubMed ID: 17110281
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Amantadine treatment is an independent predictor of improved survival in Parkinson's disease.
    Uitti RJ; Rajput AH; Ahlskog JE; Offord KP; Schroeder DR; Ho MM; Prasad M; Rajput A; Basran P
    Neurology; 1996 Jun; 46(6):1551-6. PubMed ID: 8649547
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The EQ-5D--a generic quality of life measure-is a useful instrument to measure quality of life in patients with Parkinson's disease.
    Schrag A; Selai C; Jahanshahi M; Quinn NP
    J Neurol Neurosurg Psychiatry; 2000 Jul; 69(1):67-73. PubMed ID: 10864606
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Development and validation of prognostic survival models in newly diagnosed Parkinson's disease.
    Macleod AD; Dalen I; Tysnes OB; Larsen JP; Counsell CE
    Mov Disord; 2018 Jan; 33(1):108-116. PubMed ID: 28976022
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The CamPaIGN study of Parkinson's disease: 10-year outlook in an incident population-based cohort.
    Williams-Gray CH; Mason SL; Evans JR; Foltynie T; Brayne C; Robbins TW; Barker RA
    J Neurol Neurosurg Psychiatry; 2013 Nov; 84(11):1258-64. PubMed ID: 23781007
    [TBL] [Abstract][Full Text] [Related]  

  • 14. All-cause mortality rate in patients with idiopathic pulmonary fibrosis. Implications for the design and execution of clinical trials.
    King TE; Albera C; Bradford WZ; Costabel U; du Bois RM; Leff JA; Nathan SD; Sahn SA; Valeyre D; Noble PW
    Am J Respir Crit Care Med; 2014 Apr; 189(7):825-31. PubMed ID: 24476390
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Predictors of functional dependency in Parkinson's disease.
    Macleod AD; Counsell CE
    Mov Disord; 2016 Oct; 31(10):1482-1488. PubMed ID: 27548693
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The effectiveness of creatine treatment for Parkinson's disease: an updated meta-analysis of randomized controlled trials.
    Mo JJ; Liu LY; Peng WB; Rao J; Liu Z; Cui LL
    BMC Neurol; 2017 Jun; 17(1):105. PubMed ID: 28577542
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Rasagiline, Parkinson neuroprotection, and delayed-start trials: still no satisfaction?
    Ahlskog JE; Uitti RJ
    Neurology; 2010 Apr; 74(14):1143-8. PubMed ID: 20368634
    [TBL] [Abstract][Full Text] [Related]  

  • 18. REM sleep behavior disorder predicts functional dependency in early Parkinson's disease.
    Kim R; Yoo D; Im JH; Kim HJ; Jeon B
    Parkinsonism Relat Disord; 2019 Sep; 66():138-142. PubMed ID: 31371182
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pramipexole in routine clinical practice: a prospective observational trial in Parkinson's disease.
    Reichmann H; Brecht MH; Köster J; Kraus PH; Lemke MR
    CNS Drugs; 2003; 17(13):965-73. PubMed ID: 14533946
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pergolide for levodopa-induced complications in Parkinson's disease.
    Clarke C E; Speller J M
    Cochrane Database Syst Rev; 2000; (2):CD000235. PubMed ID: 10796704
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.